Pfizer's Supreme Court challenge of US kickback law is 'far-fetched,' HHS says

The U.S. Department of Health and Human Services (HHS) has urged the Supreme Court to shoot down an appeal by Pfizer challenging the U.S. Anti-Kickback Statute (AKS).

The company wants SCOTUS to reconsider a ruling that blocks it from providing rebates to Medicare patients for its pricey heart medications Vyndaqel and Vyndamax.